White matter lesions and dementia: MRI-pathological correlation

Fukashi Udaka1, Hideyuki Sawada, Masakuni Kameyama

  • 1Department of Neurology, Sumitomo Hospital, 5-3-20 Nakanoshima, Kita-ku, Osaka 530-0005, Japan. udaka-fukashi@sumitomo-hp.or.jp

Insights

This study correlates Magnetic Resonance Imaging (MRI) findings with pathology in white matter lesions. Understanding these lesions, including dilated perivascular spaces, is crucial for evaluating cognitive function impacts.

Area of Science:

  • Neurology
  • Radiology
  • Pathology

Background:

  • White matter lesions on Magnetic Resonance Imaging (MRI) require pathological clarification.
  • Existing classifications of perivascular spaces may not fully capture pathological nuances.

Purpose of the Study:

  • To correlate MRI findings of white matter lesions with underlying pathological substrates.
  • To propose a refined classification for dilated perivascular spaces observed in brain imaging.

Main Methods:

  • An MRI-pathological correlation study was conducted.
  • Histopathological examination identified myelin loss, axonal loss, microinfarcts, astrogliosis, and dilated perivascular spaces.
  • A novel classification for dilated perivascular spaces was developed.

Main Results:

  • Pathological findings in white matter lesions included myelin and axonal loss, microinfarcts, astrogliosis, and dilated perivascular spaces.
  • A new classification for dilated perivascular spaces was proposed, categorizing them by location (e.g., état criblé in basal ganglia, white matter, or specific arterial territories).
  • Relative preservation of subcortical U-fibers was noted.

Conclusions:

  • Pathological correlates of white matter lesions on MRI are diverse, involving degenerative and vascular changes.
  • The proposed classification aids in characterizing dilated perivascular spaces.
  • Accurate tissue characterization using T2-weighted, T1-weighted, and FLAIR MRI sequences is essential for evaluating the cognitive impact of white matter lesions.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...